Anzeige
Mehr »
Freitag, 17.10.2025 - Börsentäglich über 12.000 News
Europa rüstet Drohnenabwehr auf - und diese Aktie könnte die Technologie dazu liefern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A400E3 | ISIN: FR001400N2P2 | Ticker-Symbol: 37S
Frankfurt
17.10.25 | 09:59
0,169 Euro
-10,95 % -0,021
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SPINEWAY Chart 1 Jahr
5-Tage-Chart
SPINEWAY 5-Tage-Chart
RealtimeGeldBriefZeit
0,1690,17017:14

Aktuelle News zur SPINEWAY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSpineway: Revenue growth in the third quarter117Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M...
► Artikel lesen
29.09.XFRA CAPITAL ADJUSTMENT INFORMATION - 29.09.2025313Das Instrument UDE0 AU0000179640 ARIZONA LITHIUM LTD. EQUITY wird cum Kapitalmassnahme gehandelt am 29.09.2025 und ex Kapitalmassnahme am 30.09.2025 The instrument UDE0 AU0000179640 ARIZONA LITHIUM...
► Artikel lesen
30.07.Spineway: H1 2025 results - Continued improvement in results and financial position688Press release Ecully, July 30, 2025 - 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of...
► Artikel lesen
03.07.Spineway: GMED approval for new production line dedicated to ESP prostheses - First production of LP-ESP intervertebral disc prostheses304Press release Ecully, July 3, 2025 - 6:30 p.m. SPINEWAY GMED approval for new production line dedicated to ESP prostheses First production of LP-ESP intervertebral disc prostheses Spineway...
► Artikel lesen
06.06.Spineway: Minutes of the General Meeting of June 4, 2025414Press release Ecully, June 6, 2025 - 6.00 p.m. SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders...
► Artikel lesen
SPINEWAY Aktie jetzt für 0€ handeln
19.05.Spineway: Combined General Meeting of June 4, 2025 - Availability of preparatory documents17
16.04.Spineway: First-quarter 2025 revenue of €2.8 million465Press release Ecully, April 16, 2025 - 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros20252024Change as a %Q1 revenue2,8283,070-8% Unaudited consolidated...
► Artikel lesen
24.03.Spineway: Consolidated 2024 annual results - Operating income close to breakeven937Press release Ecully, March 24, 2025 - 6 p.m. SPINEWAY Consolidated 2024 annual results Annual revenue of €12 million (+14%)Operating income close to breakevenReduction in net loss In thousands...
► Artikel lesen
22.01.Spineway: 2024 revenue of €12 million - 14% growth compared with 2023910Press release Ecully, January 22, 2025 - 6.30 p.m. SPINEWAY 2024 revenue of €12 million 14% growth compared with 2023 In thousands of euros20242023Change as a %H1 revenue6,5355,431+20%H2...
► Artikel lesen
18.12.24Spineway wins new approvals in Vietnam and registers initial orders742Press release Ecully, December 18, 2024 - 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment...
► Artikel lesen
06.12.24Spineway provides an update on its activities during a webinar - Arrival of a new CFO928Press release Ecully, December 6, 2024 - 6 p.m. Spineway provides an update on its activities during a webinarArrival of a new CFO The Spineway Group, a specialist in innovative implants for...
► Artikel lesen
04.12.24Spineway carries out a capital reduction by reducing the par value of its shares494Press release Ecully, December 4, 2024 - 8 p.m. CET Spineway carries out a capital reduction by reducing the par value of its shares The Spineway Group, a specialist in innovative implants...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3